Abstract:
전파를 이용한 이미지 센싱 장치가 개시된다. 전파를 이용한 이미지 센싱 장치는 렌즈; 그리드 어레이 안테나를 포함하고, 상기 그리드 어레이 안테나를 이용하여 상기 렌즈를 통해 집속된 전파 신호를 수신하는 안테나 모듈; 및 상기 안테나 모듈을 통해 수신된 신호를 영상 신호로 변환하기 위한 영상 처리부를 포함한다.
Abstract:
본 발명은 자연살상 세포-매개 면역반응 억제용 조성물에 관한 것으로, 더욱 구체적으로 항-CD2 항체 및 항-NKG2D 항체를 유효성분으로 포함하는 자연살상 세포에 기인하는 면역반응 억제용 조성물에 관한 것이다. 발명에 따르면, 이종장기 세포를 인식하는 다수의 자연 살상 세포 활성 수용체들 중 자연살상 세포의 활성에 가장 주요한 역할을 하는 수용체가 CD2 및 NKG2D 수용체임을 밝혀내고 이에 대한 중화항체를 이용할 경우 NK 세포에 기인하는 면역반응을 억제할 수 있다.
Abstract:
PURPOSE: An NK cell-mediated immune response inhibitor using a signal transduction inhibitor is provided to effectively suppress killing ability of NK cells and to suppress immune response. CONSTITUTION: An NK cell-mediated immune response inhibitor contains ERK(extracellular signal-regulated protein kinase) inhibitor as an active ingredient. The cell mediated immune response is acute vascular immune response. A pharmaceutical composition for suppressing xenogeneic transplantation rejection contains the NK-mediated immune response inhibitor.
Abstract:
An Mre11 protein relating to aging is provided to inhibit an aging by increasing content of the Mre11 protein in human lymphocyte through addition and transcription increase or promote the aging by decreasing concentration of the Mre11 protein in human lymphocyte. An aging is inhibited by increasing an Mre11 protein in cell by transporting the Mre11 protein into the cell, or promoting the transcription of Mre11 protein in cell. An anti-aging agent comprises the Mre11 protein. A screening method of anti-aging agent comprises the steps of: treating a testing cell with a candidate material; measuring a content of the Mre11 protein in cell of the testing cell; and increasing a content of the Mre11 protein in cell.
Abstract:
PURPOSE: A composition containing an anti-CD2 antibody and anti-NKG2D antibody is provided to suppress natural killer cell activation. CONSTITUTION: A composition for suppressing immune response in NK cells contains an anti-CD2 antibody or anti-NKG2D antibody as an active ingredient. The composition contains a combination of the anti-CD2 antibody and anti-NKG2D antibody as an active ingredient. The antibodies are a monoclonal antibody. The composition suppresses immune rejection to xenogeneic organ, tissue or cells.
Abstract:
PURPOSE: A method for controlling aging with Ku70 protein is provided to use as a pharmaceutical or cosmetic composition for delaying or suppressing aging. CONSTITUTION: An intracellular Ku70 protein prevents animal(except for human) aging by increasing the protein. An agent for preventing aging contains the intracellular Ku70 protein. A method for screening the agent comprises: a step of treating certain material to test cells; a step of measuring Ku70 protein content; and a step of selecting a material which increases the content of the intracellular Ku70 protein.